ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 706744 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 706744; 2) Community: the network communities that were significantly associated with the response to NSC 706744; 3) Molecule: the relationships between components within communities and NSC 706744; 4) MDR: the compounds that were significantly associated with the NSC 706744.

NSC Compound Enrichment Correlation
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0490935610249067 0.47974472
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0490935610249067 0.5062295
NSC 332488 1,2,4-Triazolidine-3,5-dione, 1,2,4-tris(oxiranylmethyl)- 0.0490935610249067 0.62809342
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0490935610249067 0.46734424
NSC 45236 Null 0.0490935610249067 0.2507785
NSC 47468 Null 0.0490935610249067 0.41656226
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0490935610249067 0.58115682
NSC 606497 Camptothecin Derivative 0.0490935610249067 0.8509135
NSC 606499 Camptothecin Derivative 0.0490935610249067 0.81959488
NSC 619030 Analog of CC-1065 0.0490935610249067 0.73232602
Total:54  Current:51    [First] [Prev] [Next] [Last]